Entrada Therapeutics Statistics
Total Valuation
TRDA has a market cap or net worth of $506.38 million. The enterprise value is $241.45 million.
| Market Cap | 506.38M |
| Enterprise Value | 241.45M |
Important Dates
The last earnings date was Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TRDA has 33.76 million shares outstanding. The number of shares has increased by 7.46% in one year.
| Shares Outstanding | 33.76M |
| Shares Change (YoY) | +7.46% |
| Shares Change (QoQ) | +18.61% |
| Owned by Insiders (%) | 14.31% |
| Owned by Institutions (%) | 77.47% |
| Float | 13.22M |
Valuation Ratios
The trailing PE ratio is 23.42.
| PE Ratio | 23.42 |
| Forward PE | n/a |
| PS Ratio | 3.11 |
| Forward PS | 5.60 |
| PB Ratio | 1.88 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 10.28 |
| EV / Sales | 1.48 |
| EV / EBITDA | 5.52 |
| EV / EBIT | 5.96 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.38 |
| Quick Ratio | 2.35 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.52 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.70% and return on invested capital (ROIC) is 4.10%.
| Return on Equity (ROE) | 9.70% |
| Return on Assets (ROA) | 4.80% |
| Return on Capital (ROIC) | 4.10% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | $146,781 |
| Employee Count | 160 |
| Asset Turnover | 0.33 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TRDA has paid $17.02 million in taxes.
| Income Tax | 17.02M |
| Effective Tax Rate | 42.02% |
Stock Price Statistics
The stock price has increased by +11.20% in the last 52 weeks. The beta is -0.39, so TRDA's price volatility has been lower than the market average.
| Beta (1Y) | -0.39 |
| 52-Week Price Change | +11.20% |
| 50-Day Moving Average | 13.23 |
| 200-Day Moving Average | 14.44 |
| Relative Strength Index (RSI) | 66.04 |
| Average Volume (30 Days) | 79,019 |
Short Selling Information
The latest short interest is 1.72 million, so 5.11% of the outstanding shares have been sold short.
| Short Interest | 1.72M |
| Short Previous Month | 1.75M |
| Short % of Shares Out | 5.11% |
| Short % of Float | 13.04% |
| Short Ratio (days to cover) | 22.71 |
Income Statement
In the last 12 months, TRDA had revenue of $162.87 million and earned $23.49 million in profits. Earnings per share was $0.64.
| Revenue | 162.87M |
| Gross Profit | 162.87M |
| Operating Income | 23.73M |
| Pretax Income | 40.51M |
| Net Income | 23.49M |
| EBITDA | 43.74M |
| EBIT | 40.51M |
| Earnings Per Share (EPS) | $0.64 |
Balance Sheet
The company has $331.36 million in cash and $66.43 million in debt, giving a net cash position of $264.93 million or $7.85 per share.
| Cash & Cash Equivalents | 331.36M |
| Total Debt | 66.43M |
| Net Cash | 264.93M |
| Net Cash Per Share | $7.85 |
| Equity / Book Value | 269.37M |
| Book Value Per Share | 7.98 |
| Working Capital | 240.23M |
Cash Flow
In the last 12 months, operating cash flow was -$89.12 million and capital expenditures -$4.78 million, giving a free cash flow of -$93.90 million.
| Operating Cash Flow | -89.12M |
| Capital Expenditures | -4.78M |
| Free Cash Flow | -93.90M |
| FCF Per Share | -$2.80 |
Margins
Gross margin is 100.00%, with operating and profit margins of 14.57% and 14.42%.
| Gross Margin | 100.00% |
| Operating Margin | 14.57% |
| Pretax Margin | 24.87% |
| Profit Margin | 14.42% |
| EBITDA Margin | 26.86% |
| EBIT Margin | 24.87% |
| FCF Margin | -57.65% |
Dividends & Yields
TRDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.46% |
| Shareholder Yield | -7.46% |
| Earnings Yield | 4.64% |
| FCF Yield | -18.54% |
Analyst Forecast
The average price target for TRDA is $21.00, which is 40.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 40.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 14.12% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TRDA has an Altman Z-Score of 1.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.93 |
| Piotroski F-Score | 3 |